InvestSMART

Arovella Therapeutics Limited (ASX:ALA)

ALERT: Price-sensitive ASX Announcement for ALA
Current share price for ALA : $0.052 -0.012 (-18.75%)+
Announcement
Release
20 Aug 2026 11:27AM
Price at Release
$0.064
Full Release
download
Summary
The Arovella Therapeutics Limited Annual Report for the year ending 30 June 2026 highlights a reduction in the company's losses compared to the previous year. The company reported a loss of AUD 6,916,453, down 7.9% from the previous year. The report indicates there were no revenues from ordinary activities. Despite efforts to manage expenses and the receipt of government grants and tax incentives amounting to AUD 3,498,111, the company's cash reserves decreased significantly. The report also notes that no dividends were declared during the reporting period. Changes in the company's key management personnel were noted, with several resignations occurring throughout the year.
Key Points
  • Arovella reported a loss of AUD 6,916,453 for the year ended 30 June 2026.
  • The loss decreased by 7.9% compared to the previous year.
  • There were no revenues from ordinary activities.
  • Government grants and tax incentives totaled AUD 3,498,111.
  • Cash reserves decreased significantly to AUD 14,352,901.
  • No dividends were declared during the financial year.
  • Significant changes in key management personnel occurred with multiple resignations.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.